Cost of palliative radiation to the bone for patients with bone metastases secondary to breast or prostate cancer

Radiation Oncology

Volumn 7, Issue 1, 2012, Pages

  Hess, Gregory ^a,b   Barlev, Arie ^c   Chung, Karen ^c   Hill, Jerrold W ^a   Fonseca, Eileen ^a  

^a IQVIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c AMGEN INC   (United States)

Author keywords

Bone metastases secondary to breast or prostate cancer; Cost; Palliative radiation

Indexed keywords

ADULT; AGED; ARTICLE; BONE; BONE METASTASIS; BREAST CANCER; CANCER DIAGNOSIS; CANCER LOCALIZATION; CANCER PALLIATIVE THERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; EVIDENCE BASED MEDICINE; FEMALE; HOSPITAL COST; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MULTICENTER STUDY; OBSERVATIONAL STUDY; PALLIATIVE RADIATION EPISODE OF CARE; PROSTATE CANCER; RADIATION DOSE FRACTIONATION; RETROSPECTIVE STUDY; TREATMENT OUTCOME; UNITED STATES;

AGED; BONE NEOPLASMS; BREAST NEOPLASMS; FEMALE; HEALTH CARE COSTS; HUMANS; MALE; MEDICAL RECORDS SYSTEMS, COMPUTERIZED; MIDDLE AGED; MODELS, ECONOMIC; MODELS, STATISTICAL; NEOPLASM METASTASIS; PALLIATIVE CARE; PROSTATIC NEOPLASMS; RADIOTHERAPY; RADIOTHERAPY DOSAGE; RETROSPECTIVE STUDIES;

EID: 84867320472     PISSN: None     EISSN: 1748717X     Source Type: Journal    
DOI: 10.1186/1748-717X-7-168     Document Type: Article

References (26)

1. Fairchild A, Chow E. Role of radiation therapy and radiopharmaceuticals in bone metastases. Curr Opin Support Palliat Care 2007, 1:169-173. 10.1097/SPC.0b013e3282efd70b, 18685358.
2. Rades D, Schild SE, Abrahm JL. Treatment of painful bone metastases. Nat Rev Clin Oncol 2010, 7:220-229. 10.1038/nrclinonc.2010.17, 20234353.
3. Ludwig H, Zojer N. Supportive care in multiple myeloma. Best Pract Res Clin Haematol 2007, 20:817-835. 10.1016/j.beha.2007.10.001, 18070721.
4. Tannock IF, de Wit R, Berry WR, Horti J, Pluzanska A, Chi KN, Oudard S, Theodore C, James ND, Turesson I, et al. Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer. N Engl J Med 2004, 351:1502-1512. 10.1056/NEJMoa040720, 15470213.
5. Petrylak DP, Tangen CM, Hussain MH, Lara PN, Jones JA, Taplin ME, Burch PA, Berry D, Moinpour C, Kohli M, et al. Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer. N Engl J Med 2004, 351:1513-1520. 10.1056/NEJMoa041318, 15470214.
6. Yavas O, Hayran M, Ozisik Y. Factors affecting survival in breast cancer patients following bone metastasis. Tumori 2007, 93:580-586.
7. Coleman RE. Skeletal complications of malignancy. Cancer 1997, 80:1588-1594. 10.1002/(SICI)1097-0142(19971015)80:8+<1588::AID-CNCR9>3.0.CO;2-G, 9362426.
8. Norgaard M, Jensen AO, Jacobsen JB, Cetin K, Fryzek JP, Sorensen HT. Skeletal related events, bone metastasis and survival of prostate cancer: a population based cohort study in Denmark (1999 to 2007). J Urol 2010, 184:162-167. 10.1016/j.juro.2010.03.034, 20483155.
9. Janjan N. Palliation and supportive care in radiation medicine. Hematol Oncol Clin North Am 2006, 20:187-211. 10.1016/j.hoc.2006.01.010, 16580563.
10. Nielsen OS. Palliative radiotherapy of bone metastases: there is now evidence for the use of single fractions. Radiother Oncol 1999, 52:95-96.
11. New therapies for metastatic disease addressed in updated NCCN Guidelines for breast cancer. J Natl Compr Canc Netw 2011, 9:136-222.
12. Active surveillance monitoring more stringent in updated NCCN Guidelines for prostate cancer. J Natl Compr Canc Netw 2011, 9:S-13-S-24.
13. Smith HS. Painful osseous metastases. Pain Physician 2011, 14:E373-E403.
14. Janjan N, Lutz ST, Bedwinek JM, Hartsell WF, Ng A, Pieters RS, Ratanatharathorn V, Silberstein EB, Taub RJ, Yasko AW, Rettenmaier A. Therapeutic guidelines for the treatment of bone metastasis: a report from the American College of Radiology Appropriateness Criteria Expert Panel on Radiation Oncology. J Palliat Med 2009, 12:417-426. 10.1089/jpm.2009.9633, 19416037.
15. Janjan N, Lutz ST, Bedwinek JM, Hartsell WF, Pieters RS, Silberstein EB, Yasko AW. Clinical trials and socioeconomic implication in the treatment of bone metastasis: a report from the American College of Radiology Appropriateness Criteria Expert Panel on Radiation Oncology. J Palliat Med 2009, 12:427-431. 10.1089/jpm.2009.9632, 19416038.
16. Lutz ST, Fairchild A, Chow E, Hoskin P. Background, rationale and goals for the 2010 International Consensus Conference bone metastasis treatment workshop. Clin Oncol (R Coll Radiol) 2009, 21:649-651.
17. Macklis RM, Cornelli H, Lasher J. Brief courses of palliative radiotherapy for metastatic bone pain: a pilot cost-minimization comparison with narcotic analgesics. Am J Clin Oncol 1998, 21:617-622. 10.1097/00000421-199812000-00019, 9856668.
18. Konski A, James J, Hartsell W, Leibenhaut MH, Janjan N, Curran W, Roach M, Watkins-Bruner D. Economic analysis of radiation therapy oncology group 97-14: multiple versus single fraction radiation treatment of patients with bone metastases. Am J Clin Oncol 2009, 32:423-428. 10.1097/COC.0b013e31818da9f7, 2941643, 19546803.
19. Konski A. Radiotherapy is a cost-effective palliative treatment for patients with bone metastasis from prostate cancer. Int J Radiat Oncol Biol Phys 2004, 60:1373-1378. 10.1016/j.ijrobp.2004.05.053, 15590167.
20. van den Hout WB, van der Linden YM, Steenland E, Wiggenraad RG, Kievit J, de Haes H, Leer JW. Single- versus multiple-fraction radiotherapy in patients with painful bone metastases: cost-utility analysis based on a randomized trial. J Natl Cancer Inst 2003, 95:222-229. 10.1093/jnci/95.3.222, 12569144.
21. Lutz S, Berk L, Chang E, Chow E, Hahn C, Hoskin P, Howell D, Konski A, Kachnic L, Lo S, et al. Palliative radiotherapy for bone metastases: an ASTRO evidence-based guideline. Int J Radiat Oncol Biol Phys 2011, 79:965-976. 10.1016/j.ijrobp.2010.11.026, 21277118.
22. Steenland E, Leer JW, van Houwelingen H, Post WJ, van den Hout WB, Kievit J, de Haes H, Martijn H, Oei B, Vonk E, et al. The effect of a single fraction compared to multiple fractions on painful bone metastases: a global analysis of the Dutch Bone Metastasis Study. Radiother Oncol 1999, 52:101-109. 10.1016/S0167-8140(99)00110-3, 10577695.
23. Party BPTW. 8 Gy single fraction radiotherapy for the treatment of metastatic skeletal pain: randomised comparison with a multifraction schedule over 12 months of patient follow-up. Bone Pain Trial Working Party. Radiother Oncol 1999, 52:111-121. 10.1016/S0167-8140(99)00097-3, 10577696.
24. Hartsell WF, Scott CB, Bruner DW, Scarantino CW, Ivker RA, Roach M, Suh JH, Demas WF, Movsas B, Petersen IA, et al. Randomized trial of short- versus long-course radiotherapy for palliation of painful bone metastases. J Natl Cancer Inst 2005, 97:798-804. 10.1093/jnci/dji139, 15928300.
25. Kachnic L, Berk L. Palliative single-fraction radiation therapy: how much more evidence is needed?. J Natl Cancer Inst 2005, 97:786-788. 10.1093/jnci/dji166, 15928293.
26. Hartsell WF, Konski AA, Lo SS, Hayman JA. Single fraction radiotherapy for bone metastases: clinically effective, time efficient, cost conscious and still underutilized in the United States?. Clin Oncol (R Coll Radiol) 2009, 21:652-654.